The financing was led by cultivate (MD) Ventures and joined by MedVenture Partners alongside several insider investors, including TechWald Holding, VCapital, QRM Capital, and Harmonix Fund. The funding will allow the company to launch additional partnerships and wider clinical deployments.

SentiAR was founded by Dr. Jennifer Silva, MD, FHRS, FACC, FAHA, Dr. Jonathan Silva, PhD of Washington University in St Louis and Mike Southworth, MS. SentiAR received an SBIR award from NIH alongside support from BioGenerator and Cultivation Capital to start its journey. Following the founding team's vision SentiAR has created the first application of Mixed Reality technology for use during interventional procedures, starting with cardiac ablation procedures, including the treatment of atrial fibrillation. The SentiAR platform provides an immersive command center for the clinicians by presenting a 3D hologram of the patient's electro-anatomic data in real-time. This solution gives the clinician unprecedented control via SentiAR's patent-protected, intuitive gaze interface and provides invaluable insight to guide physician diagnosis and catheter navigation.